Syndax Pharma (SNDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2025 | 12-2024 | 09-2024 | 06-2024 | 03-2024 | |
| Sales | 20,042 | 7,680 | 12,500 | 3,500 | 0 |
| Cost of Goods | 885 | N/A | N/A | N/A | N/A |
| Gross Profit | 19,157 | 6,854 | 12,500 | 3,500 | N/A |
| Operating Expenses | 103,799 | 104,045 | 102,077 | 77,716 | 79,514 |
| Operating Income | -83,757 | -96,365 | -89,577 | -74,216 | -79,514 |
| Interest Expense | 8,051 | 5,054 | 23 | 45 | 55 |
| Other Income | 6,962 | 7,250 | 5,474 | 6,198 | 7,169 |
| Pre-tax Income | -84,846 | -94,169 | -84,126 | -68,063 | -72,400 |
| Net Income Continuous | -84,846 | -94,169 | -84,126 | -68,063 | -72,400 |
| Net Income | $-84,846 | $-94,169 | $-84,126 | $-68,063 | $-72,400 |
| EPS Basic Total Ops | -0.98 | -1.09 | -0.98 | -0.80 | -0.85 |
| EPS Basic Continuous Ops | -0.98 | -1.09 | -0.98 | -0.80 | -0.85 |
| EPS Diluted Total Ops | -0.98 | -1.09 | -0.98 | -0.80 | -0.85 |
| EPS Diluted Continuous Ops | -0.98 | -1.09 | -0.98 | -0.80 | -0.85 |
| EPS Diluted Before Non-Recurring Items | -0.98 | -1.10 | -0.98 | -0.80 | N/A |
| EBITDA(a) | $-87,023 | $-99,275 | $-92,633 | $-77,862 | $-83,332 |